SONOVA HOLDING AG-REG (PHBN.DE) Stock Fundamental Analysis
Europe - FRA:PHBN - CH0012549785 - Common Stock
234.8 EUR
+1.2 (+0.51%)
Overall PHBN gets a fundamental rating of 7 out of 10. We evaluated PHBN against 60 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making PHBN a very profitable company, without any liquidiy or solvency issues. PHBN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHBN was profitable.
PHBN had a positive operating cash flow in the past year.
Each year in the past 5 years PHBN has been profitable.
PHBN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
PHBN's Return On Assets of 9.12% is amongst the best of the industry. PHBN outperforms 88.33% of its industry peers.
PHBN has a Return On Equity of 20.28%. This is amongst the best in the industry. PHBN outperforms 86.67% of its industry peers.
PHBN has a better Return On Invested Capital (11.94%) than 88.33% of its industry peers.
PHBN had an Average Return On Invested Capital over the past 3 years of 11.68%. This is above the industry average of 9.00%.
The 3 year average ROIC (11.68%) for PHBN is below the current ROIC(11.94%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 20.28% | ||
| ROIC | 11.94% |
ROA(3y)10.39%
ROA(5y)10.52%
ROE(3y)24.63%
ROE(5y)24.39%
ROIC(3y)11.68%
ROIC(5y)11.31%
1.3 Margins
PHBN has a better Profit Margin (13.98%) than 85.00% of its industry peers.
In the last couple of years the Profit Margin of PHBN has declined.
PHBN's Operating Margin of 19.41% is amongst the best of the industry. PHBN outperforms 85.00% of its industry peers.
In the last couple of years the Operating Margin of PHBN has grown nicely.
PHBN has a Gross Margin of 72.43%. This is amongst the best in the industry. PHBN outperforms 85.00% of its industry peers.
In the last couple of years the Gross Margin of PHBN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.41% | ||
| PM (TTM) | 13.98% | ||
| GM | 72.43% |
OM growth 3Y-5.82%
OM growth 5Y2.12%
PM growth 3Y-10.17%
PM growth 5Y-3.33%
GM growth 3Y-0.36%
GM growth 5Y0.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PHBN is creating value.
PHBN has about the same amout of shares outstanding than it did 1 year ago.
PHBN has less shares outstanding than it did 5 years ago.
PHBN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.35 indicates that PHBN is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.35, PHBN is doing good in the industry, outperforming 80.00% of the companies in the same industry.
The Debt to FCF ratio of PHBN is 2.22, which is a good value as it means it would take PHBN, 2.22 years of fcf income to pay off all of its debts.
PHBN has a Debt to FCF ratio of 2.22. This is amongst the best in the industry. PHBN outperforms 81.67% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that PHBN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.52, PHBN is doing worse than 61.67% of the companies in the same industry.
Although PHBN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 2.22 | ||
| Altman-Z | 4.35 |
ROIC/WACC2.61
WACC4.57%
2.3 Liquidity
A Current Ratio of 1.27 indicates that PHBN should not have too much problems paying its short term obligations.
PHBN's Current ratio of 1.27 is on the low side compared to the rest of the industry. PHBN is outperformed by 60.00% of its industry peers.
A Quick Ratio of 0.96 indicates that PHBN may have some problems paying its short term obligations.
The Quick ratio of PHBN (0.96) is comparable to the rest of the industry.
PHBN does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The earnings per share for PHBN have decreased by -9.95% in the last year.
Measured over the past 5 years, PHBN shows a small growth in Earnings Per Share. The EPS has been growing by 3.64% on average per year.
PHBN shows a small growth in Revenue. In the last year, the Revenue has grown by 6.58%.
PHBN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.79% yearly.
EPS 1Y (TTM)-9.95%
EPS 3Y-4.38%
EPS 5Y3.64%
EPS Q2Q%-6.88%
Revenue 1Y (TTM)6.58%
Revenue growth 3Y4.74%
Revenue growth 5Y5.79%
Sales Q2Q%8.45%
3.2 Future
PHBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.51% yearly.
Based on estimates for the next years, PHBN will show a small growth in Revenue. The Revenue will grow by 5.72% on average per year.
EPS Next Y18.83%
EPS Next 2Y15.41%
EPS Next 3Y13.87%
EPS Next 5Y12.51%
Revenue Next Year3.23%
Revenue Next 2Y4.61%
Revenue Next 3Y5.22%
Revenue Next 5Y5.72%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 24.23, the valuation of PHBN can be described as rather expensive.
Based on the Price/Earnings ratio, PHBN is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
PHBN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 20.40 indicates a rather expensive valuation of PHBN.
Based on the Price/Forward Earnings ratio, PHBN is valued a bit cheaper than 68.33% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, PHBN is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.23 | ||
| Fwd PE | 20.4 |
4.2 Price Multiples
70.00% of the companies in the same industry are more expensive than PHBN, based on the Enterprise Value to EBITDA ratio.
81.67% of the companies in the same industry are more expensive than PHBN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.94 | ||
| EV/EBITDA | 13.84 |
4.3 Compensation for Growth
PHBN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PHBN has an outstanding profitability rating, which may justify a higher PE ratio.
PHBN's earnings are expected to grow with 13.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.29
PEG (5Y)6.66
EPS Next 2Y15.41%
EPS Next 3Y13.87%
5. Dividend
5.1 Amount
PHBN has a Yearly Dividend Yield of 2.01%. Purely for dividend investing, there may be better candidates out there.
PHBN's Dividend Yield is rather good when compared to the industry average which is at 2.13. PHBN pays more dividend than 81.67% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, PHBN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.01% |
5.2 History
The dividend of PHBN is nicely growing with an annual growth rate of 7.88%!
Dividend Growth(5Y)7.88%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
47.40% of the earnings are spent on dividend by PHBN. This is a bit on the high side, but may be sustainable.
PHBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP47.4%
EPS Next 2Y15.41%
EPS Next 3Y13.87%
FRA:PHBN (10/3/2025, 7:00:00 PM)
234.8
+1.2 (+0.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.88%
Inst Owner ChangeN/A
Ins Owners11.45%
Ins Owner ChangeN/A
Market Cap14.00B
Analysts52.59
Price Target295.74 (25.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.01% |
Yearly Dividend4.6
Dividend Growth(5Y)7.88%
DP47.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.81%
PT rev (3m)-1.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.68%
EPS NY rev (3m)-8.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.02%
Revenue NY rev (3m)-3.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.23 | ||
| Fwd PE | 20.4 | ||
| P/S | 3.38 | ||
| P/FCF | 19.94 | ||
| P/OCF | 16.48 | ||
| P/B | 4.91 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.84 |
EPS(TTM)9.69
EY4.13%
EPS(NY)11.51
Fwd EY4.9%
FCF(TTM)11.78
FCFY5.02%
OCF(TTM)14.25
OCFY6.07%
SpS69.38
BVpS47.83
TBVpS-5.74
PEG (NY)1.29
PEG (5Y)6.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 20.28% | ||
| ROCE | 16.95% | ||
| ROIC | 11.94% | ||
| ROICexc | 14.18% | ||
| ROICexgc | 71.32% | ||
| OM | 19.41% | ||
| PM (TTM) | 13.98% | ||
| GM | 72.43% | ||
| FCFM | 16.97% |
ROA(3y)10.39%
ROA(5y)10.52%
ROE(3y)24.63%
ROE(5y)24.39%
ROIC(3y)11.68%
ROIC(5y)11.31%
ROICexc(3y)13.28%
ROICexc(5y)13.73%
ROICexgc(3y)57.29%
ROICexgc(5y)71.13%
ROCE(3y)16.59%
ROCE(5y)16.07%
ROICexcg growth 3Y-12.61%
ROICexcg growth 5Y7.75%
ROICexc growth 3Y-3.74%
ROICexc growth 5Y4.49%
OM growth 3Y-5.82%
OM growth 5Y2.12%
PM growth 3Y-10.17%
PM growth 5Y-3.33%
GM growth 3Y-0.36%
GM growth 5Y0.28%
F-Score7
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 2.22 | ||
| Debt/EBITDA | 1.39 | ||
| Cap/Depr | 55.37% | ||
| Cap/Sales | 3.56% | ||
| Interest Coverage | 28.96 | ||
| Cash Conversion | 79.48% | ||
| Profit Quality | 121.39% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 4.35 |
F-Score7
WACC4.57%
ROIC/WACC2.61
Cap/Depr(3y)57.33%
Cap/Depr(5y)52.51%
Cap/Sales(3y)3.74%
Cap/Sales(5y)3.57%
Profit Quality(3y)107.52%
Profit Quality(5y)113.47%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.95%
EPS 3Y-4.38%
EPS 5Y3.64%
EPS Q2Q%-6.88%
EPS Next Y18.83%
EPS Next 2Y15.41%
EPS Next 3Y13.87%
EPS Next 5Y12.51%
Revenue 1Y (TTM)6.58%
Revenue growth 3Y4.74%
Revenue growth 5Y5.79%
Sales Q2Q%8.45%
Revenue Next Year3.23%
Revenue Next 2Y4.61%
Revenue Next 3Y5.22%
Revenue Next 5Y5.72%
EBIT growth 1Y6.05%
EBIT growth 3Y-1.35%
EBIT growth 5Y8.03%
EBIT Next Year39.07%
EBIT Next 3Y17.31%
EBIT Next 5Y12.94%
FCF growth 1Y5.03%
FCF growth 3Y-7.7%
FCF growth 5Y-1.69%
OCF growth 1Y5.36%
OCF growth 3Y-5.52%
OCF growth 5Y-1.21%